Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2.

Song X, Song W, Wang Y, Wang J, Li Y, Qian X, Pang X, Zhang Y, Yin Y.

J Cancer. 2016 Mar 20;7(6):656-63. doi: 10.7150/jca.13674. eCollection 2016.

2.

Expression of PHF20 protein contributes to good prognosis of NSCLC and is associated with Bax expression.

Tang N, Ma L, Lin XY, Zhang Y, Yang DL, Wang EH, Qiu XS.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12198-206. eCollection 2015.

3.

Could the eIF2α-Independent Translation Be the Achilles Heel of Cancer?

Holcik M.

Front Oncol. 2015 Nov 26;5:264. doi: 10.3389/fonc.2015.00264. eCollection 2015. Review.

4.

Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E.

Hao J, Song X, Wang J, Guo C, Li Y, Li B, Zhang Y, Yin Y.

Oncotarget. 2015 Dec 8;6(39):42028-39. doi: 10.18632/oncotarget.5973.

5.

The mucolipin-2 (TRPML2) ion channel: a tissue-specific protein crucial to normal cell function.

Cuajungco MP, Silva J, Habibi A, Valadez JA.

Pflugers Arch. 2016 Feb;468(2):177-92. doi: 10.1007/s00424-015-1732-2. Epub 2015 Sep 4.

PMID:
26336837
6.

Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.

Ding M, Li J, Yu Y, Liu H, Yan Z, Wang J, Qian Q.

J Transl Med. 2015 Aug 11;13:259. doi: 10.1186/s12967-015-0609-7.

7.

CHP2 gene expression and quantitation in Egyptian patients with acute leukemia.

Hammam AA, Eissa HH, El Masry MR, Mahmoud S.

Meta Gene. 2014 May 5;2:323-31. doi: 10.1016/j.mgene.2014.04.001. eCollection 2014 Dec.

8.
9.

Tls1 regulates splicing of shelterin components to control telomeric heterochromatin assembly and telomere length.

Wang J, Tadeo X, Hou H, Andrews S, Moresco JJ, Yates JR 3rd, Nagy PL, Jia S.

Nucleic Acids Res. 2014 Oct;42(18):11419-32. doi: 10.1093/nar/gku842. Epub 2014 Sep 22.

10.

HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma.

Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR.

Onco Targets Ther. 2014 Jun 13;7:1061-70. doi: 10.2147/OTT.S61442. eCollection 2014.

11.
12.

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy.

Qin L, Smith BD, Tsai HL, Yaghi NK, Neela PH, Moake M, Fu J, Kasamon YL, Prince GT, Goswami M, Rosner GL, Levitsky HI, Hourigan CS.

Blood Cancer J. 2013 Sep 6;3:e145. doi: 10.1038/bcj.2013.44.

13.

A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients.

Akada J, Kamei S, Ito A, Ito M, Kitagawa T, Furumoto H, Kato Y, Tamesa M, Takashima M, Shirai M, Yamano H, Oka M, Kuramitsu Y, Nakamura K.

Proteome Sci. 2013 Jul 19;11(1):33. doi: 10.1186/1477-5956-11-33.

14.

PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65.

Zhang T, Park KA, Li Y, Byun HS, Jeon J, Lee Y, Hong JH, Kim JM, Huang SM, Choi SW, Kim SH, Sohn KC, Ro H, Lee JH, Lu T, Stark GR, Shen HM, Liu ZG, Park J, Hur GM.

Nat Commun. 2013;4:2062. doi: 10.1038/ncomms3062.

15.

Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2.

Pérez de Castro I, Malumbres M.

Genes Cancer. 2012 Nov;3(11-12):721-30. doi: 10.1177/1947601912473306.

16.

Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination.

Zhao W, Li Q, Ayers S, Gu Y, Shi Z, Zhu Q, Chen Y, Wang HY, Wang RF.

Cell. 2013 Feb 28;152(5):1037-50. doi: 10.1016/j.cell.2013.02.006.

17.

Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.

Sun HX, Xu Y, Yang XR, Wang WM, Bai H, Shi RY, Nayar SK, Devbhandari RP, He YZ, Zhu QF, Sun YF, Hu B, Khan M, Anders RA, Fan J.

Hepatology. 2013 Mar;57(3):1088-97. doi: 10.1002/hep.26188. Epub 2013 Feb 7.

18.

Induction of HCA587-specific antitumor immunity with HCA587 protein formulated with CpG and ISCOM in mice.

Chen J, Zhang L, Wen W, Hao J, Zeng P, Qian X, Zhang Y, Yin Y.

PLoS One. 2012;7(10):e47219. doi: 10.1371/journal.pone.0047219. Epub 2012 Oct 11.

19.

Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.

Bracci PM, Zhou M, Young S, Wiemels J.

Cancer. 2012 Nov 1;118(21):5384-94. doi: 10.1002/cncr.27538. Epub 2012 Apr 19.

20.

Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.

Grover A, Singh R, Shandilya A, Priyandoko D, Agrawal V, Bisaria VS, Wadhwa R, Kaul SC, Sundar D.

PLoS One. 2012;7(1):e30890. doi: 10.1371/journal.pone.0030890. Epub 2012 Jan 27.

Items per page

Supplemental Content

Write to the Help Desk